期刊
EUROPEAN JOURNAL OF HAEMATOLOGY
卷 110, 期 2, 页码 209-212出版社
WILEY
DOI: 10.1111/ejh.13881
关键词
BTK; COVID-19; innate immunity; monocytes; SARS-CoV-2; X-linked agammaglobulinemia
类别
An XLA patient with a 7-month course of COVID-19 showed persistent plasma SARS-CoV-2 load. The myeloid cells exhibited a sustained non-inflammatory profile, which was associated with contained severity of the disease. This suggests the potential benefit of using BTK inhibitors in SARS-CoV-2 infection.
XLA patient with 7-month course of COVID-19 with persistent plasma SARS-CoV-2 load revealed a sustained non-inflammatory profile of myeloid cells in association with contained severity of disease, arguing in favor of the use of BTK inhibitors in SARS-COV-2 infection.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据